PSNL
Diagnostics & Research · Healthcare
CEO, Board Member
2023-01-01–present
Board Member
Personalis, Inc. (PSNL)Equibles does not estimate personal net worth.
Get an email with a short summary when Personalis, Inc. publishes a filing, an earnings call transcript or a press release.
Get PSNL alertsChristopher M. Hall is recorded as Board Member at Personalis, Inc. (PSNL) since January 1, 2023 and CEO at Personalis, Inc. (PSNL). The proxy statement of Personalis, Inc. reports total compensation of $3,505,978 for Christopher M. Hall in fiscal 2025, including a base salary of $618,000. Disclosed compensation is on record for 5 fiscal years. Christopher M. Hall has spoken on 5 earnings calls across 1 company, most recently for Personalis, Inc. on November 4, 2025. Personalis, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Personalis, Inc. includes Aaron Tachibana (CEO, CFO and COO), Christopher Hall (CEO and Board Member), Karin Eastham (Chairman) and 6 others.
“Q3 was another step forward in our NNMRD strategy. We delivered 4,388 clinical tests, a 26% sequential and 364% year-over-year growth, and now have 700-plus physicians ordering next personal.”
“Our second quarter was defined by outstanding execution of our winning MRD strategy. The clinical adoption of Next Personal is accelerating dramatically, with test volume growing 59% sequentially.”
“We had a great first quarter here at Personalis, and I'm excited to update you on our progress. We achieved revenues of over $20 million this quarter and also delivered over 2,000 molecular tests.”
“I'm very proud of our team at Personalis as we continue to fight cancer with our innovative technologies. For those of you joining one of our calls for the first time, welcome.”
“2023 was a year of strong performance for Personalis, as we built a culture of execution and winning. We focused on the MRD market, reduced our annual expenses by $35 million and extended our cash runway to two years, and delivered on all of our commitments to investors, positioning our company for a pivotal 2024.”
2023-01-01–present
PSNL
Diagnostics & Research · Healthcare
CEO, Board Member
2023-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Personalis, Inc. (PSNL) | CEO | $618,000 | $3,505,978 |
| 2024 | Personalis, Inc. (PSNL) | CEO | $587,500 | $1,535,960 |
| 2023 | Personalis, Inc. (PSNL) | CEO | $533,750 | $1,726,790 |
| 2022 | Personalis, Inc. (PSNL) | CEO | $82,699 | $1,212,507 |
| 2021 | Personalis, Inc. (PSNL) | CEO | — | — |